Nuclear drug delivery for cancer chemotherapy

Journal of Controlled Release

Volumn 155, Issue 2, 2011, Pages 227-236

  Sui, Meihua ^a   Liu, Wenwen ^a   Shen, Youqing ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Biological barriers; Cancer drug delivery; Chemotherapy; DNA toxins; Nuclear drug delivery

Indexed keywords

ANTICANCER DRUG; BIOLOGICAL BARRIER; BIOLOGICAL PROPERTIES; CANCER CELLS; CANCER CHEMOTHERAPY; CANCER DRUG; CHEMOTHERAPEUTIC DRUGS; IN-VIVO; INTRACELLULAR DELIVERY; NUCLEAR DNA; NUCLEAR DRUG DELIVERY; RECENT PROGRESS; SIDE EFFECT; THERAPEUTIC EFFICACY; TUMOR CELLS;

CHEMOTHERAPY; DNA; DRUG DELIVERY; DRUG INTERACTIONS; METABOLITES; DISEASES;

DISEASES; DRUG DELIVERY;

DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NANOCARRIER; 10 HYDROXYCAMPTOTHECIN; ALPHA TOCOPHEROL; CURCUMIN; ELACRIDAR; FOLIC ACID; TARIQUIDAR;

ACIDITY; CANCER CHEMOTHERAPY; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CONFERENCE PAPER; CYTOSOL; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RESISTANCE; ENDOCYTOSIS; GENE THERAPY; IN VIVO STUDY; INTRACELLULAR MEMBRANE; LYSOSOME; MOLECULARLY TARGETED THERAPY; NUCLEAR DRUG DELIVERY; NUCLEAR LOCALIZATION SIGNAL; PERMEABILITY BARRIER; PINOCYTOSIS; POLYMERIZATION; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; TEMPERATURE SENSITIVITY; ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CELL MEMBRANE TRANSPORT; CELL NUCLEUS; CYTOTOXICITY; DRUG DESIGN; DRUG DISTRIBUTION; DRUG TRANSPORT; ENDOSOME; HUMAN; NONHUMAN;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL MEMBRANE; CELL NUCLEUS; CHEMISTRY, PHARMACEUTICAL; CYTOSOL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENDOCYTOSIS; HUMANS; NANOPARTICLES; NEOPLASMS;

EID: 80054108776     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.07.041     Document Type: Conference Paper

References (143)

1. J. Kopecek, and P. Kopeckova HPMA copolymers: origins, early developments, present, and future Adv. Drug Deliv. Rev. 62 2 2010 122 149
2. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discov. 9 8 2010 615 627
3. C.M. Paleos, D. Tsiourvas, Z. Sideratou, and L.A. Tziveleka Drug delivery using multifunctional dendrimers and hyperbranched polymers Expert Opin. Drug Deliv. 7 12 2010 1387 1398
4. J.A. Barreto, W. O'Malley, M. Kubeil, B. Graham, H. Stephan, and L. Spiccia Nanomaterials: applications in cancer imaging and therapy Adv. Mater. 23 12 2011 H18 H40
5. F. Danhier, O. Feron, and V. Preat To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control. Release 148 2 2010 135 146
6. B. Haley, and E. Frenkel Nanoparticles for drug delivery in cancer treatment Urol. Oncol. Semin. Orig. 26 1 2008 57 64
7. J.M. Harris, and R.B. Chess Effect of pegylation on pharmaceuticals Nat. Rev. Drug Discov. 2 3 2003 214 221 (Pubitemid 37361666)
8. J.D. Byrne, T. Betancourt, and L. Brannon-Peppas Active targeting schemes for nanoparticle systems in cancer therapeutics Adv. Drug Deliv. Rev. 60 15 2008 1615 1626
9. M.A. Phillips, M.L. Gran, and N.A. Peppas Targeted nanodelivery of drugs and diagnostics Nano Today 5 2 2010 143 159
10. P.G. Rose Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer Oncologist 10 3 2005 205 214 (Pubitemid 40463158)
11. F. Dosio, P. Brusa, P. Crosasso, S. Arpicco, and L. Cattel Preparation, characterization and properties in vitro and in vivo of a paclitaxel-albumin conjugate J. Control. Release 47 3 1997 293 304 (Pubitemid 27220212)
12. J.S. Murday, R.W. Siegel, J. Stein, and J.F. Wright Translational nanomedicine: status assessment and opportunities Nanomedicine 5 3 2009 251 273
13. L. Rajendran, H.J. Knolker, and K. Simons Subcellular targeting strategies for drug design and delivery Nat. Rev. Drug Discov. 9 1 2010 29 42
14. C. Friesen, M. Uhl, U. Pannicke, K. Schwarz, E. Miltner, and K.M. Debatin DNA-ligase IV and DNA-protein kinase play a critical role in deficient caspases activation in apoptosis-resistant cancer cells by using doxorubicin Mol. Biol. Cell 19 8 2008 3283 3289
15. J.H. Kim, M. Chae, W.K. Kim, Y.J. Kim, H.S. Kang, H.S. Kim, and S. Yoon Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein Br. J. Pharmacol. 162 3 2011 773 784
16. E. Wong, and C.M. Giandomenico Current status of platinum-based antitumor drugs Chem. Rev. 99 9 1999 2451 2466
17. F. Zunino, G.L. Beretta, and P. Perego Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors Expert Opin. Ther. Targets 12 10 2008 1243 1256
18. A.S. Sobolev, D.A. Jans, and A.A. Rosenkranz Targeted intracellular delivery of photosensitizers Prog. Biophys. Mol. Biol. 73 1 2000 51 90 (Pubitemid 30252106)
19. K.M. Wagstaff, and D.A. Jans Nuclear drug delivery to target tumour cells Eur. J. Pharmacol. 625 1-3 2009 174 180
20. M. Belting, S. Sandgren, and A. Wittrup Nuclear delivery of macromolecules: barriers and carriers Adv. Drug Deliv. Rev. 57 4 2005 505 527 (Pubitemid 40255558)
21. V.P. Torchilin Recent approaches to intracellular delivery of drugs and DNA and organelle targeting Annu. Rev. Biomed. Eng. 8 2006 343 375 (Pubitemid 44314821)
22. M. Breunig, S. Bauer, and A. Goefferich Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur. J. Pharm. Biopharm. 68 1 2008 112 128 (Pubitemid 350181412)
23. S.M. Burrow, D.A. Phoenix, M. Wainwright, and M.J. Tobin Intracellular localisation studies of doxorubicin and Victoria Blue BO in EMT6-S and EMT6-R cells using confocal microscopy Cytotechnology 39 1 2002 15 25 (Pubitemid 36267831)
24. M. Duvvuri, and J.P. Krise Intracellular drug sequestration events associated with the emergence of multidrug resistance: a mechanistic review Front. Biosci. 10 2005 1499 1509 (Pubitemid 40529015)
25. G.D. Wang, E. Reed, and Q.Q. Li Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review) Oncol. Rep. 12 5 2004 955 965
26. M.A. Fuertes, C. Alonso, and J.M. Perez Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance Chem. Rev. 103 3 2003 645 662
27. R.P. Perez Cellular and molecular determinants of cisplatin resistance Eur. J. Cancer 34 10 1998 1535 1542 (Pubitemid 28446333)
28. J.M. Escoffre, J. Teissie, and M.P. Rols Gene transfer: how can the biological barriers be overcome? J. Membr. Biol. 236 1 2010 61 74
29. K.M. Wagstaff, and D.A. Jans Nucleocytoplasmic transport of DNA: enhancing non-viral gene transfer Biochem. J. 406 2007 185 202 (Pubitemid 47310949)
30. C. Pichon, L. Billiet, and P. Midoux Chemical vectors for gene delivery: uptake and intracellular trafficking Curr. Opin. Biotech. 21 5 2010 640 645
31. E.A. Dubikovskaya, S.H. Thorne, T.H. Pillow, C.H. Contag, and P.A. Wender Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters Proc. Natl. Acad. Sci. USA 105 34 2008 12128 12133
32. R. Duncan, and L. Izzo Dendrimer biocompatibility and toxicity Adv. Drug Deliv Rev. 57 15 2005 2215 2237 (Pubitemid 41759394)
33. S. Kim, Y.Z. Shi, J.Y. Kim, K. Park, and J.X. Cheng Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction Expert Opin. Drug Deliv. 7 1 2010 49 62
34. F. Alexis, E. Pridgen, L.K. Molnar, and O.C. Farokhzad Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol. Pharm. 5 4 2008 505 515
35. N.T. Huynh, E. Roger, N. Lautram, J.P. Benoit, and C. Passirani The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting Nanomedicine-Uk 5 9 2010 1415 1433
36. A. Arnida, M.M. Janat-Amsbury, A. Ray, C.M. Peterson, and H. Ghandehari Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages Eur. J. Pharm. Biopharm. 77 3 2011 417 423
37. K. Zhang, R. Rossin, A. Hagooly, Z.Y. Chen, M.J. Welch, and K.L. Wooley Folate-mediated cell uptake of shell-crosslinked spheres and cylinders J. Polym. Sci. Polym. Chem. 46 22 2008 7578 7583
38. S. Shah, Y. Liu, W. Hu, and J.M. Gao Modeling particle shape-dependent dynamics in nanomedicine J. Nanosci. Nanotech. 11 2 2011 919 928
39. S.D. Li, and L. Huang Pharmacokinetics and biodistribution of nanoparticles Mol. Pharm. 5 4 2008 496 504
40. K.D. Jensen, A. Nori, M. Tijerina, P. Kopeckova, and J. Kopecek Cytoplasmic delivery and nuclear targeting of synthetic macromolecules J. Control. Release 87 1-3 2003 89 105 (Pubitemid 36258389)
41. D.C. Litzinger, A.M.J. Buiting, N. Vanrooijen, and L. Huang Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes BBA-Biomembranes 1190 1 1994 99 107 (Pubitemid 24066264)
42. G. Sahay, D.Y. Alakhova, and A.V. Kabanov Endocytosis of nanomedicines J. Control. Release 145 3 2010 182 195
43. H. Sato, Y. Sugiyama, A. Tsuji, and I. Horikoshi Importance of receptor-mediated endocytosis in peptide delivery and targeting: kinetic aspects Adv. Drug Deliv. Rev. 19 3 1996 445 467 (Pubitemid 26227530)
44. L. Sadowski, I. Pilecka, and M. Miaczynska Signaling from endosomes: location makes a difference Exp. Cell Res. 315 9 2009 1601 1609
45. C.P. Leamon, and J.A. Reddy Folate-targeted chemotherapy Adv. Drug Deliv. Rev. 56 8 2004 1127 1141 (Pubitemid 38496512)
46. N.M. Zaki, and N. Tirelli Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting Expert Opin. Drug Deliv. 7 8 2010 895 913
47. J.Z. Gasiorowski, and D.A. Dean Mechanisms of nuclear transport and interventions Adv. Drug Deliv. Rev. 55 6 2003 703 716 (Pubitemid 36644163)
48. 3 particles and the application as anticancer drug carrier J. Am. Chem. Soc. 130 47 2008 15808 15810
49. G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity Pharmacol. Rev. 56 2 2004 185 229 (Pubitemid 38720829)
50. K. Kiyomiya, S. Matsuo, and M. Kurebe Mechanism of specific nuclear transport of adriamycin: the mode of nuclear translocation of adriamycin-proteasome complex Cancer Res. 61 6 2001 2467 2471 (Pubitemid 32685825)
51. M. Shi, K. Ho, A. Keating, and M.S. Shoichet Doxorubicin-conjugated immuno-nanoparticles for intracellular anticancer drug delivery Adv. Funct. Mater. 19 11 2009 1689 1696
52. C. Cuvier, L. Roblottreupel, J.M. Millot, G. Lizard, S. Chevillard, M. Manfait, P. Couvreur, and M.F. Poupon Doxorubicin-loaded nanospheres bypass tumor-cell multidrug resistance Biochem. Pharmacol. 44 3 1992 509 517
53. T.A. Elbayoumi, and V.P. Torchilin Enhanced cytotoxicity of monoclonal anticancer antibody 2 C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines Eur. J. Pharm. Sci. 32 3 2007 159 168 (Pubitemid 47532709)
54. D. Goren, A.T. Horowitz, D. Tzemach, M. Tarshish, S. Zalipsky, and A. Gabizon Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump Clin. Cancer Res. 6 5 2000 1949 1957 (Pubitemid 30305094)
55. X.G. Li, D.J. Hirsh, D. Cabral-Lilly, A. Zirkel, S.M. Gruner, A.S. Janoff, and W.R. Perkins Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient BBA-Biomembranes 1415 1 1998 23 40 (Pubitemid 29050759)
56. S. Eksborg Extraction of daunorubicin and doxorubicin and their hydroxyl metabolites-self-association in aqueous-solution J. Pharm. Sci-US 67 6 1978 782 785 (Pubitemid 8355234)
57. M. Menozzi, L. Valentini, E. Vannini, and F. Arcamone Self-association of doxorubicin and related-compounds in aqueous-solution J. Pharm. Sci-US 73 6 1984 766 770
58. E.V. Batrakova, and A.V. Kabanov Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers J. Control. Release 130 2 2008 98 106
59. E.V. Batrakova, S. Li, V.Y. Alakhov, W.F. Elmquist, D.W. Miller, and A.V. Kabanov Sensitization of cells overexpressing multidrug-resistant proteins by Pluronic P85 Pharm. Res. 20 10 2003 1581 1590 (Pubitemid 37268272)
60. E.V. Batrakova, S. Li, A.M. Brynskikh, A.K. Sharma, Y.L. Li, M. Boska, N. Gong, R.L. Mosley, V.Y. Alakhov, H.E. Gendelman, and A.V. Kabanov Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers J. Control. Release 143 3 2010 290 301
61. A.V. Kabanov, E.V. Batrakova, and V.Y. Alakhov An essential relationship between ATP depletion and chemosensitizing activity of Pluronic((R)) block copolymers J. Control. Release 91 1-2 2003 75 83 (Pubitemid 37288878)
62. Y. Patil, T. Sadhukha, L.N. Ma, and J. Panyam Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance J. Control. Release 136 1 2009 21 29
63. S. Ganta, and M. Amiji Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells Mol. Pharm. 6 3 2009 928 939
64. H.L. Wong, R. Bendayan, A.M. Rauth, and X.Y. Wu Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid Hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer J. Control. Release 116 3 2006 275 284 (Pubitemid 44827405)
65. P.Y. Li, P.S. Lai, W.C. Hung, and W.J. Syu Poly(L-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells Biomacromolecules 11 10 2010 2576 2582
66. M. Abbasi, A. Lavasanifar, L.G. Berthiaume, M. Weinfeld, and H. Uludag Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells Cancer 116 23 2010 5544 5554
67. Y.C. Chen, S.R. Bathula, J. Li, and L. Huang Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer J. Biol. Chem. 285 29 2010 22639 22650
68. Y.B. Patil, S.K. Swaminathan, T. Sadhukha, L.A. Ma, and J. Panyam The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance Biomaterials 31 2 2010 358 365
69. D.S.W. Benoit, S.M. Henry, A.D. Shubin, A.S. Hoffman, and P.S. Stayton pH-responsive polymeric siRNA carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of polo-like kinase 1 Mol. Pharm. 7 2 2010 442 455
70. M. Susa, A.K. Iyer, K. Ryu, E. Choy, F.J. Hornicek, H. Mankin, L. Milane, M.M. Amiji, and Z. Duan Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma Plos One 5 5 2010
71. S. Yadav, L.E. van Vlerken, S.R. Little, and M.M. Amiji Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells Cancer Chemoth. Pharm. 63 4 2009 711 722
72. R.I. Pakunlu, Y. Wang, M. Saad, J.J. Khandare, V. Starovoytov, and T. Minko In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug J. Control. Release 114 2 2006 153 162 (Pubitemid 44291853)
73. D.J. Yoon, C.T. Liu, D.S. Quinlan, P.M. Nafisi, and D.T. Kamei Intracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer Annu. Biomed. Eng. 39 4 2011 1235 1251
74. P.S. Low, and S.A. Kularatne Folate-targeted therapeutic and imaging agents for cancer Curr. Opin. Chem. Biol. 13 3 2009 256 262
75. P.S. Xu, E.A. Van Kirk, Y.H. Zhan, W.J. Murdoch, M. Radosz, and Y. Shen Targeted charge-reversal nanoparticles for nuclear drug delivery Angew. Chem. Int. Edit. 46 26 2007 4999 5002 (Pubitemid 47055979)
76. Y. Shen, Z.X. Zhuo, M.H. Sui, J.B. Tang, P.S. Xu, E.A. Van Kirk, W.J. Murdoch, M.H. Fan, and M. Radosz Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery Nanomedicine-Uk 5 8 2010 1205 1217
77. Z.X. Zhou, Y. Shen, J.B. Tang, M.H. Fan, E.A. Van Kirk, W.J. Murdoch, and M. Radosz Charge-reversal drug conjugate for targeted cancer cell nuclear drug delivery Adv. Funct. Mater. 19 22 2009 3580 3589
78. S. Dhar, Z. Liu, J. Thomale, H.J. Dai, and S.J. Lippard Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device J. Am. Chem. Soc. 130 34 2008 11467 11476
79. V. Anbharasi, N. Cao, and S.S. Feng Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy J. Biomed. Mater. Res. A 94 3 2010 730 743
80. J.J. Khandare, P. Chandna, Y. Wang, V.P. Pozharov, and T. Minko Novel polymeric prodrug with multivalent components for cancer therapy J. Pharmacol. Exp. Ther. 317 3 2006 929 937 (Pubitemid 43764094)
81. G. Ashwell, and A.G. Morell Role of surface carbohydrates in hepatic recognition and transport of circulating glycoproteins Adv. Enzymol. Relat. Areas Mol. Biol. 41 1974 99 128
82. A.L. Schwartz The hepatic asialoglycoprotein receptor CRC Crit. Rev. Biochem. 16 3 1984 207 233
83. W. Wei, Z.G. Yue, J.B. Qu, H. Yue, Z.G. Su, and G.H. Ma Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: an in vitro evaluation Nanomedicine-Uk 5 4 2010 589 596
84. N. Kolishetti, S. Dhar, P.M. Valencia, L.Q. Lin, R. Karnik, S.J. Lippard, R. Langer, and O.C. Farokhzad Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy Proc. Natl. Acad. Sci. USA 107 42 2010 17939 17944
85. X.B. Xiong, Z.S. Ma, R. Lai, and A. Lavasanifar The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin Biomaterials 31 4 2010 757 768
86. X.B. Xiong, A. Mahmud, H. Uludag, and A. Lavasanifar Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells Pharm. Res. 25 11 2008 2555 2566
87. D.J. Yoon, D.S.H. Chu, C.W. Ng, E.A. Pham, A.B. Mason, D.M. Hudson, V.C. Smith, R.T.A. MacGillivray, and D.T. Kamei Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins J. Control. Release 133 3 2009 178 184
88. M.H. Hong, S.J. Zhu, Y.Y. Jiang, G.T. Tang, and Y.Y. Pei Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin J. Control. Release 133 2 2009 96 102
89. T. Noh, Y.H. Kook, C. Park, H. Youn, H. Kim, E.T. Oh, E.K. Choi, H.J. Park, and C. Kim Block copolymer micelles conjugated with anti-EGFR antibody for targeted delivery of anticancer drug J. Polym. Sci. Polym. Chem. 46 22 2008 7321 7331
90. T.P. Thomas, R. Shukla, A. Kotlyar, J. Kukowska-Latallo, and J.R. Baker Dendrimer-based tumor cell targeting of fibroblast growth factor-1 Bioorg. Med. Chem. Lett. 20 2 2010 700 703
91. H. Lee, H. Fonge, B. Hoang, R.M. Reilly, and C. Allen The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles Mol. Pharm. 7 4 2010 1195 1208
92. R.M. Steinman, I.S. Mellman, W.A. Muller, and Z.A. Cohn Endocytosis and the recycling of plasma-membrane J. Cell Biol. 96 1 1983 1 27
93. S. Ganta, H. Devalapally, A. Shahiwala, and M. Amiji A review of stimuli-responsive nanocarriers for drug and gene delivery J. Control. Release 126 3 2008 187 204
94. H. Yuan, K. Luo, Y.S. Lai, Y.J. Pu, B. He, G. Wang, Y. Wu, and Z.W. Gu A novel poly(L-glutamic acid) dendrimer based drug delivery system with both pH-sensitive and targeting functions Mol. Pharm. 7 4 2010 953 962
95. X.Q. Yang, J.J. Grailer, S. Pilla, D.A. Steeber, and S.Q. Gong Tumor-targeting, pH-responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapy Bioconjugate Chem. 21 3 2010 496 504
96. B. Rihova, T. Etrych, M. Pechar, M. Jelinkova, M. Stastny, O. Hovorka, M. Kovar, and K. Ulbrich Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes J. Control. Release 74 1-3 2001 225 232 (Pubitemid 32727624)
97. P.S. Lai, P.J. Lou, C.L. Peng, C.L. Pai, W.N. Yen, M.Y. Huang, T.H. Young, and M.J. Shieh Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy J. Control. Release 122 1 2007 39 46
98. T. Minko, P. Kopeckova, V. Pozharov, and J. Kopecek HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line J. Control. Release 54 2 1998 223 233 (Pubitemid 28342701)
99. Y. Kasuya, Z.R. Lu, P. Kopeckova, T. Minko, S.E. Tabibi, and J. Kopecek Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates J. Control. Release 74 1-3 2001 203 211 (Pubitemid 32727622)
100. A. Nan, H. Ghandehari, C. Hebert, H. Siavash, N. Nikitakis, M. Reynolds, and J.J. Sauk Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck J. Drug Target. 13 3 2005 189 197 (Pubitemid 40668172)
101. E.S. Lee, K. Na, and Y.H. Bae Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor J. Control. Release 103 2 2005 405 418 (Pubitemid 40342538)
102. K.S. Soppimath, L.H. Liu, W.Y. Seow, S.Q. Liu, R. Powell, P. Chan, and Y.Y. Yang Multifunctional core/shell nanoparticles self-assembled from pH-induced thermosensitive polymers for targeted intracellular anticancer drug delivery Adv. Funct. Mater. 17 3 2007 355 362
103. K.S. Soppimath, D.C.W. Tan, and Y.Y. Yang pH-Triggered thermally responsive polymer core-shell nanoparticles for drug delivery Adv. Mater. 17 3 2005 318 323 (Pubitemid 40320152)
104. G. Begum, S. Singh, N. Rangaraj, G. Srinivas, and R.K. Rana Cellular permeation with nuclear infiltration capability of biomimetically synthesised fluorescent monodisperse mesoporous silica nanospheres in HeLa and human stem cells J. Mater. Chem. 20 39 2010 8563 8570
105. Z.P. Xu, M. Niebert, K. Porazik, T.L. Walker, H.M. Cooper, A.P.J. Middelberg, P.P. Gray, P.F. Bartlett, and G.Q. Lu Subcellular compartment targeting of layered double hydroxide nanoparticles J. Control. Release 130 1 2008 86 94
106. T.R. Kyriakides, C.Y. Cheung, N. Murthy, P. Bornstein, P.S. Stayton, and A.S. Hoffman pH-Sensitive polymers that enhance intracellular drug delivery in vivo J. Control. Release 78 1-3 2002 295 303 (Pubitemid 34081874)
107. R.A. Jones, C.Y. Cheung, F.E. Black, J.K. Zia, P.S. Stayton, A.S. Hoffman, and M.R. Wilson Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles Biochem. J. 372 2003 65 75 (Pubitemid 36609607)
108. M.A. Yessine, and J.C. Leroux Membrane-destabilizing polyanions: interaction with lipid bilayers and endosomal escape of biomacromolecules Adv. Drug Deliv. Rev. 56 7 2004 999 1021
109. J. Rinne, B. Albarran, J. Jylhava, T.O. Ihalainen, P. Kankaanpaa, V.P. Hytonen, P.S. Stayton, M.S. Kulomaa, and M. Vihinen-Ranta Internalization of novel non-viral vector TAT-streptavidin into human cells BMC Biotechnol. 7 2007
110. B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts, and J.D. Watson Molecular biology of the cell M. Robertson, Intracellular Sorting and the Maintenance of Cellular Compartments 1989 Garland Publishing Inc New York 407
111. R. Tonini, F. Grohovaz, C.A.M. Laporta, and M. Mazzanti Gating mechanism of the nuclear pore complex channel in isolated neonatal and adult mouse liver nuclei FASEB J. 13 11 1999 1395 1403 (Pubitemid 29382507)
112. H. Sakurai, M. Okamoto, M. Hasegawa, T. Satoh, M. Oikawa, T. Kamiya, K. Arakawa, and T. Nakano Direct visualization and quantification of the anticancer agent, cis-diamminedichloro-platinum(II), in human lung cancer cells using in-air microparticle-induced X-ray emission analysis Cancer Sci. 99 5 2008 901 904 (Pubitemid 351997591)
113. C. Molenaar, J.M. Teuben, R.J. Heetebrij, H.J. Tanke, and J. Reedijk New insights in the cellular processing of platinum antitumor compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy J. Biol. Inorg. Chem. 5 5 2000 655 665
114. G. Speelmans, R.W.H.M. Staffhorst, and B. deKruijff The anionic phospholipid-mediated membrane interaction of the anti-cancer drug doxorubicin is enhanced by phosphatidylethanolamine compared to other zwitterionic phospholipids Biochemistry 36 28 1997 8657 8662 (Pubitemid 27305151)
115. T. Betancourt, B. Brown, and L. Brannon-Peppas Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation Nanomedicine-Uk 2 2 2007 219 232 (Pubitemid 46845768)
116. C. Deduve, T. Debarsy, B. Poole, A. Trouet, P. Tulkens, and F. Vanhoof Lysosomotropic agents Biochem. Pharmacol. 23 18 1974 2495 2531
117. M. Duvvuri, S. Konkar, R.S. Funk, J.M. Krise, and J.P. Krise A chemical strategy to manipulate the intracellular localization of drugs in resistant cancer cells Biochemistry 44 48 2005 15743 15749 (Pubitemid 41746905)
118. A. Bulychev, A. Trouet, and P. Tulkens Uptake and intracellular- distribution of neutral red in cultured fibroblasts Exp. Cell Res. 115 2 1978 343 355 (Pubitemid 9040392)
119. M. Duvvuri, and J.P. Krise A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pH-partitioning theory would predict Mol. Pharm. 2 6 2005 440 448 (Pubitemid 43016385)
120. S. Owatari, S. Akune, M. Komatsu, R. Ikeda, S.D. Firth, X.F. Che, M. Yamamoto, K. Tsujikawa, M. Kitazono, T. Ishizawa, T. Takeuchi, T. Aikou, J.F.B. Mercer, S. Akiyama, and T. Furukawa Copper-transporting P-type ATPase, ATP7A, confers multidrug resistance and its expression is related to resistance to SN-38 in clinical colon cancer Cancer Res. 67 10 2007 4860 4868 (Pubitemid 46910194)
121. R. Safaei, K. Katano, B.J. Larson, G. Samimi, A.K. Holzer, W. Naerdemann, M. Tomioka, M. Goodman, and S.B. Howell Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells Clin. Cancer Res. 11 2 2005 756 767 (Pubitemid 40116905)
122. N. Baldini, K. Scotlandi, M. Serra, T. Shikita, N. Zini, A. Ognibene, S. Santi, R. Ferracini, and N.M. Maraldi Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell-lines showing similar mechanisms of doxorubicin distribution Eur. J. Cell Biol. 68 3 1995 226 239
123. D.M. Bradshaw, and R.J. Arceci Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance J. Clin. Oncol. 16 11 1998 3674 3690 (Pubitemid 28506783)
124. C.M. Feldherr, and D. Akin Regulation of nuclear transport in proliferating and quiescent cells Exp. Cell Res. 205 1 1993 179 186 (Pubitemid 23192118)
125. J.P. Cheng, K.A.S. Fernando, L.M. Veca, Y.P. Sun, A.I. Lamond, Y.W. Lam, and S.H. Cheng Reversible accumulation of PEGylated single-walled carbon nanotubes in the mammalian nucleus ACS Nano 2 10 2008 2085 2094
126. S.K. Lai, K. Hida, C. Chen, and J. Hanes Characterization of the intracellular dynamics of a non-degradative pathway accessed by polymer nanoparticles J. Control. Release 125 2 2008 107 111 (Pubitemid 350299609)
127. G.W. Moseley, D.L. Leyton, D.J. Glover, R.P. Filmer, and D.A. Jans Enhancement of protein transduction-mediated nuclear delivery by interaction with dynein/microtubules J. Biotechnol. 145 3 2010 222 225
128. J. You, F.Q. Hu, Y.Z. Du, and H. Yuan Improved cytotoxicity of doxorubicin by enhancing its nuclear delivery mediated via nanosized micelles Nanotechnology 19 25 2008 1 8
129. H.V. Kuusisto, K.M. Wagstaff, G. Alvisi, and D.A. Jans The C-terminus of apoptin represents a unique tumor cell-enhanced nuclear targeting module Int. J. Cancer 123 12 2008 2965 2969
130. R. Misra, and S.K. Sahoo Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy Eur. J. Pharm. Sci. 39 1-3 2010 152 163
131. O. Aronov, A.T. Horowitz, A. Gabizon, M.A. Fuertes, J.M. Perez, and D. Gibson Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues Bioconjugate Chem. 15 4 2004 814 823 (Pubitemid 38981956)
132. D. Sarko, B. Beijer, R.G. Boy, E.M. Nothelfer, K. Leotta, M. Eisenhut, A. Altmann, U. Haberkorn, and W. Mier The pharmacokinetics of cell-penetrating peptides Mol. Pharm. 7 6 2010 2224 2231
133. S.R. Schwarze, A. Ho, A. Vocero-Akbani, and S.F. Dowdy In vivo protein transduction: delivery of a biologically active protein into the mouse Science 285 5433 1999 1569 1572 (Pubitemid 29420581)
134. V.A. Sethuraman, and Y.H. Bae TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors J. Control. Release 118 2 2007 216 224 (Pubitemid 46350711)
135. E.S. Lee, Z.G. Gao, D. Kim, K. Park, I.C. Kwon, and Y.H. Bae Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance J. Control. Release 129 3 2008 228 236
136. W. Zauner, M. Ogris, and E. Wagner Polylysine-based transfection systems utilizing receptor-mediated delivery Adv. Drug Deliv. Rev. 30 1-3 1998 97 113 (Pubitemid 28201908)
137. J. Suh, D. Wirtz, and J. Hanes Efficient active transport of gene nanocarriers to the cell nucleus Proc. Natl. Acad. Sci. USA 100 7 2003 3878 3882 (Pubitemid 36418125)
138. S.P. Hong, P.R. Leroueil, E.K. Janus, J.L. Peters, M.M. Kober, M.T. Islam, B.G. Orr, J.R. Baker, and M.M.B. Holl Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability Bioconjugate Chem. 17 3 2006 728 734 (Pubitemid 43794383)
139. T.P. Thomas, R. Shukla, A. Kotlyar, B. Liang, J.Y. Ye, T.B. Norris, and J.R. Baker Dendrimer-epidermal growth factor conjugate displays superagonist activity Biomacromolecules 9 2 2008 603 609 (Pubitemid 351298484)
140. R. Savic, L.B. Luo, A. Eisenberg, and D. Maysinger Micellar nanocontainers distribute to defined cytoplasmic organelles Science 300 5619 2003 615 618 (Pubitemid 36520581)
141. V. Labhasetwar Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery Curr. Opin. Biotech. 16 6 2005 674 680 (Pubitemid 41654647)
142. J.P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M.J. Gait, L.V. Chernomordik, and B. Lebleu Cell-penetrating peptides - a reevaluation of the mechanism of cellular uptake J. Biol. Chem. 278 1 2003 585 590 (Pubitemid 36043612)
143. M. Lundberg, and M. Johansson Positively charged DNA-binding proteins cause apparent cell membrane translocation Biochem. Bioph. Res. Commun. 291 2 2002 367 371 (Pubitemid 34694414)